Wharton Health Care

LifeSci Beat

Business EN ↓ 22 episodes

LifeSci Beat is a Wharton MBA student-run podcast dedicated to exploring the business of innovation in the life sciences. We are focused on chronicling the latest discoveries in life sciences (biotech, medtech, diagnostics, and more) and uncovering the business challenges faced by leaders in bringing cutting edge technology to market.

Be sure to visit the podcast's website and support the creator: rss.com

Author

Wharton Health Care

Category

Business

Podcast website

rss.com

Latest episode

Apr 2, 2024

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Dr. James Min, Founder & CEO of Cleerly Health, on Building a Cardiology Care Management Platform 02.04.2024

In the third episode of Season 3, we spoke with Dr. James Min, Founder and CEO of Cleerly Health, about his experience turning his clinical research into Cleerly and how he’s managed the business as the treatment of coronary artery disease evolves thanks to new research, new technology like generative AI, or new business models like value-based care reimbursement. Our discuss touches on processes...

Dr. Barthalomew (B.A.) Sillah, COO of Avesta76 Therapeutics, on Company Creation and Driving Inclusion in Biotech 13.02.2024

In the second episode of Season 3, we spoke with Dr. Barthalomew Sillah, COO of Avesta76 therapeutics about his experiences turning innovative science into impactful therapeutics. Our conversation touched on being open-minded to new opportunities, learning from non-biotech experiences in the healthcare ecosystem, and championing inclusion in the industry.

Eshwar Inapuri, Former CEO & Co-Founder of InnaMed, on Founding Diagnostics Companies 21.01.2024

In the first episode of Season 3 of LifeSci Beat, we chatted with Eshwar Inapuri, Former CEO & Co-Founder of InnaMed. Our conversation spanned diagnostics company creation, navigating challenges as a young entrepreneur, and new frontiers and trends in the diagnostics space. InnaMed is an at-home blood testing company focused on improving the monitoring and treatment of patients undergoing hear...

James Mutamba, CBO of Arrakis Therapeutics, on Biotech BD and IPO financing 04.05.2023

In this episode, we chatted with Dr. James Mutamba, CBO of Arrakis Therapeutics. Our conversation covered biotech IPO financing, the process of business development dealmaking, company creation, and the Arrakis Therapeutics platform. Arrakis Therapeutics is an preclinical private biotech developing RNA-targeted small molecules. They combine insights into RNA structure, chemistry, and biology to pi...

Oriana Papin-Zoghbi on Revolutionizing Early-stage Ovarian Cancer Diagnosis 16.04.2023

In this ninth episode, we spoke with Oriana Papin-Zoghbi, co-founder and CEO of AOA Dx. We discussed her global upbringing and early career, the current standard of ovarian cancer diagnosis, and building a company from academic research.

Alex Sapir, Former CEO of ReViral Ltd. and Dova Pharmaceuticals, on Advancing Pipeline Candidates and Financing Biotech Companies 03.04.2023

In the eighth episode of this season, we chatted with Alex Sapir about his various experiences leading life sciences companies through commercial launches and key funding milestones. We spoke about his career beginnings at GSK, ZS Associates, and United Therapeutics. Additionally, we covered his CEO tenures at Dova Pharmaceuticals and ReViral Ltd - both of which were acquired.

Geoff Meyerson, CEO & Co-Founder of Locust Walk, on Building a Global Biotech Advisory Firm 28.02.2023

In this episode, we sat down with Geoff Meyerson — CEO & Co-Founder at Locust Walk. We discuss Geoff’s extensive life science career, which includes stints in investment banking, venture capital, and business development. We also dive into the founding story and journey of Locust Walk, a global investment bank that integrates corporate development strategy and execution with ​capital raising f...

Dr. Pitou Devgon, Co-Founder of Velano Vascular, on Creating Value in a Commoditized Device Market 13.02.2023

In the sixth episode of our second season, we sat down with Dr. Pitamber "Pitou" Devgon, co-founder of Velano Vascular, active angel investor, and Lecturer at the Wharton School of Business. We discussed the origins of Velano Vascular’s central PIVO™ technology, the importance of collecting insightful data to de-risk early ventures, innovation through acquisition, and much more. Founded in 2012, V...

Imogen Pryce, COO of R&D at Relay Therapeutics, on the Dynamo Platform and Portfolio Strategy 01.02.2023

In this episode, we chatted with Dr. Imogen Pryce, COO of R&D at Relay Therapeutics. Our conversation covered Relay Therapeutics’ scientific strategy, its unique Dynamo™ platform, and its underlying commercialization strategy and scientific differentiation. Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicines company that integrates disparate technologies to push drug disc...

Rami Elghandour, Chairman & CEO of Arcellx, on Building Great Teams & Cultures 20.01.2023

In the fourth episode of our second season, we spoke with Rami Elghandour, Chairman & CEO of Arcellx. Our conversation focused on the importance of building a company's culture from day one and how firms can turn their cultures into a competitive advantage. Arcellx is a clinical stage biotech company reimagining cell therapy. The company recently announced a strategic collaboration with Kite.

Ankit Mahadevia, CEO of Spero Therapeutics, on Leadership in Biotechnology and Innovation in Antibiotic Development 05.12.2022

In the third episode of our second season, we spoke with Dr. Ankit Mahadevia, CEO of Spero Therapeutics and former Venture Partner at Atlas Venture. Our conversation focused on the benefits of diverse exposure within the healthcare ecosystem, unique challenges of developing antibiotics, and leadership lessons learned through a prolonged career company creation. Spero Therapeutics is a public compa...

Leo Grady Ph.D. on Leveraging AI to Impact Healthcare 07.11.2022

On the second episode of this season, we chatted with Leo Grady Ph. D. Our conversation focused on his career working at medical technology companies and the many applications of AI in healthcare. Leo is internationally recognized for his work to deliver AI in healthcare for 20 years at the multinational medical company Siemens and pioneering startups HeartFlow and Paige. AI. As CEO of Paige, Leo...

Kiersten Stead, Managing Partner at DCVC Bio, on Deep TechBio Company Creation 23.10.2022

In the first episode of our second season, we chatted with Dr. Kiersten Stead, Managing Partner at DCVC Bio. Our conversation focused on computational drug discovery, her latest investments, and the keys to company creation in this burgeoning space. DCVC Bio is the bio-focused arm of DCVC, a VC with $3B+ in AUM focused on deep-tech investing, where Kiersten invests in therapeutics, agriculture, an...

John Evans, CEO of Beam Therapeutics, on the Business of Biotech 31.05.2022

In our final episode of our first season, we chatted with John Evans, CEO of Beam Therapeutics. Our conversation spans lessons in commercializing therapies across the development life cycle, programmable gene editing platforms, evaluating biopharma partnerships, future trends in gene therapy accessibility, and more. Beam Therapeutics is a leader in the nascent gene editing space, pioneering propri...

Brian Harris, CEO and Co-Founder of MedRhythms, on Pioneering the Next Generation of Digital Therapeutics Using Music to Improve Walking 24.04.2022

In this episode, we spoke with Brian Harris, CEO and Co-Founder of MedRhythms. We explore Brian’s upbringing and how his passion for music and desire to help people manifested into the career he has today. We dive into his career as a music therapist which led to the creation of MedRhythms. MedRhythms uses sensors, music, and software to build digital therapeutics that aim to improve walking impai...

Enoch Kariuki, Former CEO of Lengo Therapeutics, on Translating Science to Therapies 18.04.2022

In this episode, we sat down with Dr. Enoch Kariuki – former CEO at Lengo Therapeutics, CFO at VelosBio, and SVP of Corporate Development at Synthorx. We explore Enoch’s upbringing in Kenya and how a family member’s battle with HIV inspired his pursuit of a career in healthcare. We also dive into Enoch’s journey as a biotech executive at three separate start-ups, all of which were acquired. Enoch...

Lalo Flores, CEO at Century Therapeutics, on Developing Next-Generation Cell Therapies 20.03.2022

In this episode, we sat down with Dr. Osvaldo (Lalo) Flores, CEO at Century Therapeutics. We discuss Lalo's early career in R&D, the founding story (and eventual acquisition) of Novira Therapeutics, and his outlook on next-generation cell therapies with Century. Century Therapeutics is a biotechnology company developing transformative allogeneic cell therapies to create products for both hemat...

Dr. Ali Behbahani, Partner at NEA, on evaluating and investing in cutting-edge life sciences 13.02.2022

In this episode, we sat down with Dr. Ali Behbahani, General Partner at New Enterprise Associates. Dr. Behbahani has been with NEA since 2007, spearheading over 40 biotech and medtech investments such as CRISPR Therapeutics, Adaptimmune, and Nevro. We discussed his views on breaking into VC, his approach to assessing early-stage life science innovations, the current trends in the biotech investing...

Karun Naga, Partner at The Foundry, on Creating Medical Technologies and Building Innovative Companies 09.01.2022

In this episode, we sat down with Karun Naga, Partner at The Foundry, a leading venture studio focused on building pioneering life-saving medical technologies. We discuss the business model of The Foundry, Karun's early career journey that led him to medical device start-ups, his successful start-ups and the acquisition process, and much more. The Foundry is a team of entrepreneurs committed to in...

Molly Gibson, Co-Founder of Generate Biomedicines, on Innovating at the Intersection of AI/ML and Biotech 12.12.2021

In this episode, we chatted with Molly Gibson, Co-Founder of Generate Biomedicines, a biotech that uses AI/ML to generate protein medicines and recently closed a $370M Series B financing. We discussed the key trends in computationally-powered drug discovery and bioplatforms, what it takes to commercialize early-stage biotechnology, and much more. Founded in 2018 under the Flagship Pioneering ecosy...

Jamil Beg, Partner at 5AM Ventures, on Building and Investing in Innovative Biotech Companies 15.11.2021

In this episode, we sat down with Jamil Beg, Partner at 5AM Ventures, a leading venture capital firm focused on building next-generation life science companies. We discuss Jamil's career journey, the challenges in scaling early-stage biotech companies, the current life science investing landscape, and much more. Founded in 2002, 5AM has invested in 100 companies and raised over $2.0 billion since...

Welcome to LifeSci Beat! 09.11.2021

Welcome to our introductory episode of the LifeSci Beat. Here, we briefly cover our goals and motivation for the podcast and introduce our hosts: Shubham Chatterjee, Jaclyn Kawwas, and Kevin Nguyen. Stay tuned for our first interview, coming soon!

Listen to the LifeSci Beat podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.